The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis

Blood

Volumn 121, Issue 16, 2013, Pages 3228-3236

  Zou, Zhiying ^a   Enis, David R ^a   Bui, Hung ^a   Khandros, Eugene ^b   Kumar, Vinayak ^a   Jakus, Zoltan ^a   Thom, Christopher ^b   Yang, Yiqing ^a   Dhillon, Veerpal ^a   Chen, Mei ^a   Lu, MinMin ^a   Weiss, Mitchell J ^b   Kahn, Mark L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD71 ANTIGEN; COLLAGEN AND CALCIUM BINDING EPIDERMAL GROWTH FACTOR DOMAINCONTAINING PROTEIN 1; DESMIN; ERYTHROPOIETIN; GENOMIC DNA; HEMOGLOBIN; HERMES ANTIGEN; METHYLCELLULOSE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; STEM CELL FACTOR; TER119 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VON WILLEBRAND FACTOR; CALCIUM BINDING PROTEIN; CCBE1 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CELL MATURATION; CELL PROLIFERATION; CELL STRESS; CFU COUNTING; CONTROLLED STUDY; EMBRYO; ERYTHROBLAST; ERYTHROBLASTIC ISLAND; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FETUS LIVER; GENE DELETION; HEMATOPOIETIC CELL; KNOCKOUT MOUSE; LYMPHANGIOGENESIS; MACROPHAGE FUNCTION; MOUSE; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CYTOLOGY; EMBRYO DEATH; FETUS; GENETICS; LIVER; LYMPHATIC SYSTEM; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT;

ANEMIA; ANIMALS; BONE MARROW; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; EMBRYO LOSS; EMBRYO, MAMMALIAN; ERYTHROBLASTS; ERYTHROPOIESIS; ERYTHROPOIETIN; FETUS; GENE DELETION; LIVER; LYMPHATIC SYSTEM; MICE; STEM CELL FACTOR; TUMOR SUPPRESSOR PROTEINS;

MLCS; MLOWN;

EID: 84879182120     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-10-462689     Document Type: Article

References (32)

1. van der Putten K, Braam B, Jie KE, Gaillard CA. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol. 2008;4(1):47-57.
2. Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood. 2011;118(24):6258-6268.
3. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990; 248(4953):378-381.
4. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012; 481(7382):457-462.
5. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3): 470-478.
6. Bessis M. [Erythroblastic island, functional unity of bone marrow] Rev Hematol. 1958;13(1):8-11.
7. Manwani D, Bieker JJ. The erythroblastic island. Curr Top Dev Biol. 2008;82:23-53.
8. Kawane K, Fukuyama H, Kondoh G, Takeda J, Ohsawa Y, Uchiyama Y, Nagata S. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science. 2001;292(5521):1546-1549.
9. Yoshida H, Kawane K, Koike M, Mori Y, Uchiyama Y, Nagata S. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature. 2005;437(7059):754-758.
10. Soni S, Bala S, Gwynn B, Sahr KE, Peters LL, Hanspal M. Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J Biol Chem. 2006;281(29): 20181-20189.
11. Fabriek BO, Polfliet MM, Vloet RP, et al. The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood. 2007; 109(12):5223-5229.
12. Liu XS, Li XH, Wang Y, et al. Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver. Blood. 2007;110(3):870-876.
13. Kusakabe M, Hasegawa K, Hamada M, et al. c-Maf plays a crucial role for the definitive erythropoiesis that accompanies erythroblastic island formation in the fetal liver. Blood. 2011; 118(5):1374-1385.
14. Hogan BM, Bos FL, Bussmann J, Witte M, Chi NC, Duckers HJ, Schulte-Merker S. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet. 2009;41(4): 396-398.
15. Alders M, Hogan BM, Gjini E, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41(12): 1272-1274.
16. Van Balkom ID, Alders M, Allanson J, et al. Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am J Med Genet. 2002;112(4):412-421.
17. Bos FL, Caunt M, Peterson-Maduro J, et al. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res. 2011;109(5):486-491.
18. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67(2): 295-301.
19. Brice G, Child AH, Evans A, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42(2):98-102.
20. Stadtfeld M, Graf T. Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development. 2005;132(1):203-213.
21. Ruzankina Y, Pinzon-Guzman C, Asare A, et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell. 2007;1(1):113-126.
22. Kingsley PD, Malik J, Fantauzzo KA, Palis J. Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis. Blood. 2004; 104(1):19-25.
23. Fraser ST, Isern J, Baron MH. Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression. Blood. 2007;109(1):343-352.
24. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 1999;98(2): 181-191.
25. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA. 2009; 106(41):17413-17418.
26. Lee G, Lo A, Short SA, et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood. 2006;108(6):2064-2071.
27. Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood. 2005;105(7):2741-2748.
28. Connell F, Kalidas K, Ostergaard P, et al; Lymphoedema Consortium. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet. 2010;127(2): 231-241.
29. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74-80.
30. Zhang L, Zhou F, Han W, Shen B, Luo J, Shibuya M, He Y. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 2010;20(12): 1319-1331.
31. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322(5909):1839-1842.
32. Xu J, Shao Z, Glass K, et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev Cell. 2012; 23(4):796-811.